Atractylodin ameliorates bleomycin-induced pulmonary inflammation and fibrosis in mice

• Main Authors: Zhenhui Wu (Author), Jinhua Fu (Author), Shufang Zhang (Author), Yihao Huang (Author), Jiang Xu (Author), Miaoxin Zhu (Author), Shanghua Chen (Author), Liang Ye (Author), Meigui You (Author), Jie Wang (Author), Xue Yi (Author), Yaping Xu (Author)
• Format: Book
• Published: Elsevier, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease. The commonly used drugs for the treatment of pulmonary fibrosis can only delay the damage of lung function but cannot prolong the life of patients. Atractylodin (ATR), a kind of herbal medicine that has been proven...